Identification of the essential and critical factors of decision-making for COVID-19 patient management: a mixed-method study
Background: Understanding the contributing factors for decision-making based on the disease stage is highly crucial to improving patient care. Aim: This study aimed to identify the critical and essential factors to enhance clinical decision-making for COVID-19 patients.
Methods: This mixed-method research was conducted in two phases. In the first phase, a systematic literature review was performed using defined search strategies across four databases, including PubMed, Scopus, Web of Science, and IEEE. A total of 136 studies were obtained. Next, a questionnaire-based survey was conducted to validate the findings from the review and to categorize the factors into essential and critical factors. The content validity ratio was used to categorize the factors accordingly. The identified factors were classified into six main categories based on the stages of care and the corresponding decision-making.
Results: The expert panel consisted of 10 clinicians from various fields. The potential factors were categorized into six categories. A total of 293 factors were found in the literature review. The findings of the consensus survey revealed 10 factors related to the decisions on the length of stay, eight factors for ward referral decisions, one factor for decisions on home referrals, six factors for deterioration diagnosis decisions, two factors for discharge decisions, and 10 factors for decisions on intensive care unit referrals. In addition, the study identified respiratory rate, oxygen saturation at administration, arterial oxygen pressure, sequential organ failure assessment score, and glomerular filtration rate as significant decision-making factors for COVID-19 patient management.
Conclusion: For medical emergencies (e.g., COVID-19 management), fewer but more significant factors may increase the efficiency of decision-making, thereby improving the quality of patient management. On this basis, this study identified the essential and critical factors for decision-making at different stages of COVID-19 patient management.
Relevance for Patients: This study identified the most important factors in diagnosing the deterioration of COVID-19 patients to improve the treatment outcome of COVID-19 patients.
[1] Wu Y, Ho W, Huang Y, Jin DY, Li S, Liu SL, et al. SARSCoV-2 is an Appropriate Name for the New Coronavirus. Lancet 2020;395:949-50. doi: 10.1016/S0140-6736(20)30557-2
[2] Mandal B. The Global Emergence of Severe Acute Respiratory Syndrome Coronavirus 2 in Human. Virusdisease 2020;31:67-70. doi: 10.1007/s13337-020-00613-y
[3] Killeen GF, Kiware SS. Why Lockdown? Why National Unity? Why Global Solidarity? Simplified Arithmetic Toolsfor Decision-Makers, Health Professionals, Journalists and the General Public to Explore Containment Options for the 2019 Novel Coronavirus. Infect Dis Model 2020;5:442-58. doi: 10.1016/j.idm.2020.06.006
[4] Gambrill E. Critical Thinking in Clinical Practice: Improving the Quality of Judgments and Decisions. United States: Wiley; 2006.
[5] Merow C, Urban MC. Seasonality and Uncertainty in Global COVID-19 Growth Rates. Proc Nat Acad Sci U S A 2020;117:27456-64. doi: 10.1073/pnas.2008590117
[6] Koffman J, Gross J, Etkind SN, Selman L. Uncertainty and COVID-19: How are we to Respond? J R Soc Med 2020;113:211-6. doi: 10.1177/0141076820930665
[7] Alsalem MA, Alamoodi AH, Albahri OS, Dawood KA, Mohammed RT, Alnoor A, et al. Multi-Criteria DecisionMaking for Coronavirus Disease 2019 Applications: A Theoretical Analysis Review. Artif Intell Rev 2022;55:4979-5062. doi: 10.1007/s10462-021-10124-x
[8] Raboisson D, Lhermie G. Living with COVID-19: ASystemic and Multi-Criteria Approach to Enact EvidenceBased Health Policy. Front Public Health 2020;8:294. doi: 10.3389/fpubh.2020.00294
[9] Oliveira E, Parikh A, Lopez-Ruiz A, Carrilo M, Goldberg J, Cearras M, et al. ICU Outcomes and Survival in Patients with Severe COVID-19 in the Largest Health Care System in Central Florida. PLoS One 2021;16:e0249038. doi: 10.1371/journal.pone.0249038
[10] Bijani M, Abedi S, Karimi S, Tehranineshat B. Major Challenges and Barriers in Clinical Decision-Making as Perceived by Emergency Medical Services Personnel: A Qualitative Content Analysis. BMC Emerg Med 2021;21:11. doi: 10.1186/s12873-021-00408-4
[11] Marewski JN, Gigerenzer G. Heuristic Decision Making in Medicine. Dialogues Clin Neurosci 2012;14:77-89. doi: 10.31887/DCNS.2012.14.1/jmarewski
[12] Rousseau DM. Making Evidence-Based Organizational Decisions in an Uncertain World. Organ Dyn 2018;47:135-46. doi: 10.1016/j.orgdyn.2020.100756
[13] Jordan RE, Adab P, Cheng K. Covid-19: Risk Factors for Severe Disease and Death. BMJ 2020;368:m1198. doi: 10.1136/bmj.m1198
[14] Caramelo F, Ferreira N, Oliveiros B. Estimation of Risk Factors for COVID-19 Mortality-Preliminary Results. MedRxiv; 2020.
[15] Rod J, Oviedo-Trespalacios O, Cortes-Ramirez J. A BriefReview of the Risk Factors for Covid-19 Severity. Rev Saude Publica 2020;54:60. doi: 10.11606/s1518-8787.2020054002481
[16] Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors Associated with COVID-19- related death using OpenSAFELY. Nature 2020;584:430. doi: 10.1038/s41586-020-2521-4
[17] Aggour M, Tran Chi C, Fiehler J. Patient Prioritization and Management During the COVID-19 Pandemic. Interv Neuroradiol 2021;27 1 Suppl:19-23. doi: 10.1177/15910199211035302
[18] De Nardo P, Gentilotti E, Mazzaferri F, Cremonini E, Hansen P, Goossens H, et al. Multi-Criteria Decision Analysis to Prioritize Hospital Admission of Patients Affected by COVID-19 in Low-Resource Settings with Hospital-Bed Shortage. Int J Infect Dis 2020;98:494-500. doi: 10.1016/j.ijid.2020.06.082
[19] Bringedal BH, Rø KI, Bååthe F, Miljeteig I, Magelssen M. Guidelines and clinical priority setting during the COVID-19 pandemic-Norwegian doctors’ experiences. BMC Health Serv Res 2022;22:1192. doi: 10.1186/s12913-022-08582-2
[20] Özkan B, Özceylan E, Kabak M, Dikmen AU. Evaluation of Criteria and COVID-19 Patients for Intensive Care Unit Admission in the Era of Pandemic: A Multi-Criteria Decision Making Approach. Comput Methods Programs Biomed 2021;209:106348. doi: 10.1016/j.cmpb.2021.106348
[21] Hosseini Sarkhosh SM, Taghvaei M, Allameh SF. Prioritization of COVID-19 Patients for Admission in the Intensive Care Unit in the Context of Hospital Bed Shortages: An Integrated Multi-criteria Decision Making Approach. Q J Manage Strategies Health Syst 2022;7:125-39.
[22] Ceruti S, Glotta A, Biggiogero M, Maida PA, Marzano M, Urso P, et al. Admission Criteria in Critically ill COVID-19 Patients: A Physiology-Based Approach. PLoS One 2021;16:e0260318. doi: 10.1371/journal.pone.0260318
[23] Hsu CH, Chiu CL, Lin YT, Yu AY, Kang YT, Cherng M, et al. Triage Admission Protocol with a Centralized Quarantine Unit for Patients after Acute Care Surgery During the COVID-19 Pandemic: A Tertiary Center Experience in Taiwan. PLoS One 2022;17:e0263688. doi: 10.1371/journal.pone.0263688
[24] Metlay JP, Armstrong KA. Clinical Decision Making During the COVID-19 Pandemic. Ann Intern Med 2021;174:691-3. doi: 10.7326/M20-8179
[25] Lo Bianco G, Di Pietro S, Mazzuca E, Imburgia A, Tarantino L, Accurso G, et al. Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review. Front Pharmacol 2020;11:572168.doi: 10.3389/fphar.2020.572168
[26] Shorten A, Smith J. Mixed Methods Research: Expanding the Evidence Base. Evid Based Nurs 2017;20:74-5. doi: 10.1136/eb-2017-102699
[27] Wallace BC, Kuiper J, Sharma A, Zhu M, Marshall IJ. Extracting PICO Sentences from Clinical Trial Reports using Supervised Distant Supervision. J Mach Learn Res 2016;17:132.
[28] Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097
[29] Kahn DA, Docherty JP, Carpenter D, Frances A. Consensus Methods in Practice Guideline Development: A Review and Description of a New Method. Psychopharmacol Bull 1997;33:631-9.
[30] Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, et al. The Expert Consensus Guideline Series: Adherence Problems in Patients with Serious and Persistent Mental Illness. J Clin Psychiatry 2009;70 Suppl 4:1-46, quiz 7-8.
[31] Ayre C, Scally AJ. Critical Values for Lawshe’s Content Validity Ratio: Revisiting the original methods of Calculation. Meas Eval Couns Dev 2014;47:79-86.
[32] Lawshe CH. A Quantitative Approach to Content Validity. Pers Psychol 1975;28:563-75. doi: 10.1111/j.1744-6570.1975.tb01393.x
[33] Khazaee-Pool M, Shoghli A, Pashaei T, Ponnet K. Psychometric Properties of the Persian Version of the Cancer Attitude Inventory. BMC Public Health 2019;19:1402. doi: 10.1186/s12889-019-7756-3
[34] Zamanzadeh V, Ghahramanian A, Rassouli M, Abbaszadeh A, Alavi-Majd H, Nikanfar AR. Design and Implementation Content Validity Study: Development of an Instrument for Measuring Patient-Centered Communication. J Caring Sci 2015;4:165-78. doi: 10.15171/jcs.2015.017
[35] Ayyoubzadeh SM, Ghazisaeedi M, Rostam Niakan Kalhori S, Hassaniazad M, Baniasadi T, Maghooli K, et al. A Study of Factors Related to Patients’ Length of Stay Using Data Mining Techniques in a General Hospital in Southern Iran. Health Inf Sci Syst 2020;8:9. doi: 10.1007/s13755-020-0099-8
[36] Mukhtar A, Rady A, Hasanin A, Lotfy A, El Adawy A, Hussein A, et al. Admission SpO2 and ROX Index Predict Outcome in Patients with COVID-19. Am J Emerg Med 2021;50:106-10. doi: 10.1016/j.ajem.2021.07.049
[37] Miller DJ, Capodilupo JV, Lastella M, Sargent C, RoachGD, Lee VH, et al. Analyzing Changes in Respiratory Rate to Predict the Risk of COVID-19 Infection. PLoS One 2020;15:e0243693. doi: 10.1371/journal.pone.024369
[38] Pijls BG, Jolani S, Atherley A, Derckx RT, Dijkstra JI, Franssen GH, et al. Demographic Risk Factors for COVID-19 Infection, Severity, ICU Admission and Death: A Meta-Analysis of 59 Studies. BMJ Open 2021;11:e044640. doi: 10.1136/bmjopen-2020-044640
[39] McKinstry B, Alexander H, Maxwell G, Blaikie L, Patel S, Guthrie B. The Use of Telemonitoring in Managing the COVID-19 Pandemic: Pilot Implementation Study. JMIR Form Res 2021;5:e20131. doi: 10.2196/20131
[40] Pryor R, Atkinson C, Cooper K, Doll M, Godbout E, Stevens MP, et al. The Electronic Medical Record and COVID-19: Is it up to the Challenge? Am J Infect Control 2020;48:966-7. doi: 10.1016/j.ajic.2020.05.002
[41] Madhavan S, Bastarache L, Brown JS, Butte AJ, Dorr DA, Embi PJ, et al. Use of Electronic Health Records to Support a Public Health Response to the COVID-19 pandemic in the United States: A perspective from 15 academic medical centers. J Am Med Inform Assoc 2020;28:393-401. doi: 10.1093/jamia/ocaa287
[42] Philips K, Uong A, Buckenmyer T, Cabana MD, Hsu D, Katyal C, et al. Rapid Implementation of an Adult Coronavirus Disease 2019 Unit in a Children’s Hospital. J Pediatr 2020;222:22-7. doi: 10.1016/j.jpeds.2020.04.060
[43] Carley S, Horner D, Body R, Mackway-Jones K. Evidencebased medicine and COVID-19: What to believe and when to change. Emerg Med J 2020;37:572-5. doi: 10.1136/emermed-2020-210098
[44] Nan S, Tang T, Feng H, Wang Y, Li M, Lu X, et al. A Computer-Interpretable Guideline for COVID-19: Rapid Development and Dissemination. JMIR Med Inform 2020;8:e21628. doi: 10.2196/21628
[45] Wu G, Yang P, Xie Y, Woodruff HC, Rao X, Guiot J, et al. Development of a Clinical Decision Support System for Severity Risk Prediction and Triage of COVID-19 Patients at Hospital Admission: An International Multicentre Study. Eur Respir J 2020;56:2001104. doi: 10.1183/13993003.01104-2020
[46] Karim H, Ravandi MH, Zandesh Z, Naserpoor A, Yasini M, Kalhori SR, et al. A unique framework for the Persian Clinical Guidelines: Addressing an Evidence-Based CDSS Development Need. BMJ Evid Based Med 2020;25:22-6. doi: 10.1136/bmjebm-2019-111187
[47] Sherimon V, Puliprathu Cherian S, Mathew R, Kumar SM, Nair RV, Shaikh K, et al. Clinical Decision Support for Primary Health Centers to Combat COVID-19 Pandemic. In: Intelligent Systems. Germany: Springer; 2021. p. 481-90.
[48] Mellitus D. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2005;28:S5-10. doi: 10.2337/diacare.28.suppl_1.s37
[49] Garg AD, Agostinis P. Cell Death and Immunity in Cancer: From Danger Signals to Mimicry of Pathogen Defense Responses. Immunol Rev 2017;280:126-48. doi: 10.1111/imr.12574
[50] Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer Treatment and Survivorship Statistics, 2019. CA Cancer J Clin 2019;69:363-85. doi: 10.3322/caac.21565
[51] Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Petersen SE, et al. European Society of Cardiology: Cardiovascular Disease Statistics 2019. Eur Heart J 2019;41:12-85. doi: 10.1093/eurheartj/ehz859
[52] Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of Chronic Kidney Disease in China: A CrossSectional Survey. Lancet 2012;379:815-22. doi: 10.1016/S0140-6736(12)60033-6
[53] Hansell DM. Classification of Diffuse Lung Diseases: Why and How. Radiology 2013;268:628-40. doi: 10.1148/radiol.13120908
[54] Rosselli M, MacNaughtan J, Jalan R, Pinzani M. Beyond Scoring: A Modern Interpretation of Disease Progression in Chronic Liver Disease. Gut 2013;62:1234-41. doi: 10.1136/gutjnl-2012-302826
[55] Rose NR. Autoimmune Diseases. In: Quah SR, editor. International Encyclopedia of Public Health. 2nd ed. Oxford: Academic Press; 2017. p. 192-5.
[56] Krensky M, Bennett M, Vincenti F. In: Brunton LL, editor. Immunosuppressants, Tolerogens, and Immunostimulants. McGraw-Hill Education; 2011. p. 1005-31.
[57] Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. Hypertension and COVID-19. United States. Country in North America. Oxford University Press; 2020.
[58] Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining Comorbidity: Implications for Understanding Health and Health Services. Ann Fam Med 2009;7:357-63. doi: 10.1370/afm.983
[59] George-Gay B, Parker K. Understanding the Complete Blood Count with Differential. J Perianesth Nurs 2003;18:96-114, quiz 115-7. doi: 10.1053/jpan.2003.50013
[60] Walker HK, Hall WD, Hurst JW. Clinical Methods: The History, Physical, and Laboratory Examinations. Boston: Butterworths; 1990.
[61] Tanaka T, Narazaki M, Kishimoto T. IL-6 in Inflammation, Immunity, and Disease. Cold Spring Harb Perspect Biol 2014;6:a016295. doi: 10.1101/cshperspect.a016295
[62] Lala V, Goyal A, Bansal P, Minter DA. Liver Function Tests. In: StatPearls. Treasure Island, FL: StatPearls; 2021.
[63] Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al. COVID-19: Abnormal Liver Function Tests. J Hepatol 2020;73:566-74. doi: 10.1016/j.jhep.2020.04.006
[64] Takeda Y, Takeda Y, Tomimoto S, Tani T, Narita H, Kimura G. Bilirubin as a Prognostic Marker in Patients with Pulmonary Arterial Hypertension. BMC Pulmonary Med 2010;10:22. doi: 10.1186/1471-2466-10-22
[65] Lala V, Goyal A, Farhana A, Lappin SL. Biochemistry, Lactate Dehydrogenase. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2021.
[66] Du Clos TW, Mold C. C-Reactive Protein: An Activator of Innate Immunity and a Modulator of Adaptive Immunity. Immunol Res 2004;30:261-77. doi: 10.1385/IR:30:3:261
[67] Creamer AW, Kent AE, Albur M. Procalcitonin in Respiratory Disease: Use as a Biomarker for Diagnosis and Guiding Antibiotic Therapy. Breathe (Sheff) 2019;15:296-304. doi: 10.1183/20734735.0258-2019
[68] Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the Clinician. Blood Rev 2009;23:95-104. doi: 10.1016/j.blre.2008.08.001
[69] Sharma S, Jackson PG, Makan J. Cardiac Troponins. J Clin Pathol 2004;57:1025-6. doi: 10.1136/jcp.2003.015420
[70] Tripodi A. D-Dimer Testing in Laboratory Practice. Clin Chem 2011;57:1256-62. doi: 10.1373/clinchem.2011.166249
[71] Hepner M, Karlaftis V. Antithrombin. Methods Mol Biol 2013;992:355-64. doi: 10.1007/978-1-62703-339-8_28
[72] Herrick S, Blanc-Brude O, Gray A, Laurent G. Fibrinogen. Int J Biochem Cell Biol 1999;31:741-6. doi: 10.1016/s1357-2725(99)00032-1
[73] Inker LA, Levey AS, Coresh J. Estimated Glomerular Filtration Rate from a Panel of Filtration Markers-Hope for Increased Accuracy Beyond Measured Glomerular Filtration Rate? Adv Chronic Kidney Dis 2018;25:67-75. doi: 10.1053/j.ackd.2017.10.004
[74] Magee F, Wilson A, Bailey M, Pilcher D, Gabbe B, Bellomo R. Comparison of Intensive Care and Traumaspecific Scoring Systems in Critically Ill Patients. Injury 2021;52:2543-50. doi: 10.1016/j.injury.2021.03.049
[75] Hewett JN, Rodgers GW, Chase JG, Le Compte AJ, Pretty CG, Shaw GM. Assessment of SOFA Score as a Diagnostic Indicator in Intensive Care Medicine. IFAC Proc Vol 2012;45:467-72.
[76] Nguyen Y, Corre F, Honsel V, Curac S, Zarrouk V, Fantin B, et al. Applicability of the CURB-65 Pneumonia Severity Score for Outpatient Treatment of COVID-19. J Infect 2020;81:e96-8. doi: 10.1016/j.jinf.2020.05.049
[77] Gupta GP, Nair RR, Jeyanthi R. An ANN based SpO2 Measurement for Clinical Management Systems. Energy Proced 2017;117:393-400.
[78] Zhang JM, An J. Cytokines, Inflammation, and Pain. Int Anesthesiol Clin 2007;45:27-37. doi: 10.1097/AIA.0b013e318034194e
[79] Cao Z, Jia Y, Zhu B. BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine. Int J Mol Sci 2019;20:1820. doi: 10.3390/ijms20081820
[80] Dolak İ, Keçili R, Onat R, Ziyadanoğulları B, Ersöz A, Say R. Molecularly Imprinted Affinity Cryogels for the Selective Recognition of Myoglobin in Blood Serum. J Mol Struct 2018;1174:171-6. doi: 10.1016/j.molstruc.2018.03.126